Source: Dia a Diaes

Residents of Itapemirim who tested positive for coronavirus will receive free, starting this Wednesday (1) the HCQ, which is composed of the drugs ivermectin, zinc, azithromycin and hydroxychloroquine.

According to the City Hall of Itapemirim, the delivery of medicines will be made exclusively to the two Sentinel units in the municipality, specific for patients with symptoms of coronavirus, located in Vila and Itaipava.

Before receiving the kit, the patient undergoes an examination to prove the disease. For this, the city announced the purchase, through bidding, of the rapid tests that will allow testing between 2 to 3 thousand people.

With regard to the kit, the city recalls that the patient has the choice of whether or not to use the drugs and that, if he wishes to receive them, he will sign a term of responsibility and authorization.

Purchase delay

The initial forecast, according to Mayor Thiago Peçanha, was that the drugs were already available until the 23rd of last month, however, there was a delay in the purchase of the products.

The city stressed, by means of a note, that it opted to bid on medicines, as it was safer, more cohesive and transparent. However, he explained, at the opening of the dispute, which occurred on the 25th, he managed to acquire two of the four drugs that make up the kit.

“Due to the need for acquisition, after bidding, we decided to purchase the other two drugs through dispensation. We even got a price quote in the lower amount than we expected in the bidding process ”, said the city hall, in a note.

Related:

Treatment with Hydroxychloroquine Cut Death Rate Significantly in COVID-19 Patients, Henry Ford Health System Study Shows

C19 Study: 48 studies (28 peer reviewed) showing “very positive” results using HCQ as pre & post exposure prophylaxis & early treatment.

Covid-19: Portugal without cases of “adverse reactions” to hydroxychloroquine

HIBISCUS: Hydroxychloroquine for the Secondary Prevention of Thrombotic and Obstetrical Events in Primary Antiphospholipid Syndrome

Chronic treatment with hydroxychloroquine and SARS-CoV-2 infection.

Share on facebook
Share on twitter
Share on whatsapp
On Trend

Latest Stories

Stark madness to ban ivermectin

Buried in the note is the real reason for making ivermectin inaccessible – the fear that persons taking it ‘may elect not to be vaccinated as part of the national Covid-19 vaccination program’. This is outrageous. When someone is infected with Covid, it is too late to bother with vaccination. They need early treatment. To deny it to coerce them into accepting a vaccine, one of whose side-effects is death, is immoral.

Read More »

Australia’s TGA Bans GPs from Prescribing Ivermectin

Australia’s medicine and therapeutic regulatory, the Therapeutic Good Administration (TGA) recently took the gloves off with Ivermectin, the economical anti-parasitic drug associated with at least 63 completed clinical trials involving SARS-CoV-2, the virus behind COVID-19. Now TGA formally places a national prohibition on off-label prescribing of ivermectin to all general practitioners. A comparable move as to what TGA did with hydroxychloroquine in 2020. Clearly further evidence of tightening encroachment of the critically important doctor-patient treatment relationship allowing consent to medical treatment using off-label medications. Of course, this isn’t occurring in a vacuum—it’s part of an unfolding, integrated and what have the signs of a coordinated and orchestrated government action to stop any and all treatments other than those the government declares acceptable.

Read More »